Glenmark: Glenmark Pharmaceuticals Exhibits Strong Performance Amid Market Volatility and Sector Gains
Glenmark Pharmaceuticals has demonstrated strong performance, gaining 3.03% today and achieving a total return of 3.53% over the last two days. The stock has shown high volatility and is trading above key moving averages, with impressive long-term growth compared to the broader market.
Read full article »
Glenmark Pharma is an India-based pharmaceutical company that develops, manufactures, and supplies generic drugs and active pharmaceutical ingredients.
Read more